Efficacy and safety of the preclose technique following percutaneous aortic stent-graft implantation

Won Ho Kim, Sanghoon Shin, Young Guk Ko, Myeong Ki Hong, Yangsoo Jang, Donghoon Choi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Purpose: To evaluate in a large patient cohort the 6-F Perclose ProGlide in conjunction with the preclose technique to seal puncture sites after percutaneous endovascular aortic repairs. Methods: The medical records were reviewed of 367 patients (303 men; mean age 68.5±10.8 years) having 599 access site closures with the 6-F Perclose ProGlide performed in conjunction with percutaneous endovascular aortic repairs. Procedure success was defined as hemostasis with the preclose technique without the need for any ancillary procedure. Access-related major adverse events included infection, bleeding, lower leg ischemia, hematoma, pseudoaneurysm, arteriovenous fistula, embolization, laceration, femoral artery thrombosis, nerve injury, or death owing to an access site injury. Results: Procedure success was achieved in 359 (97.8%) of 367 patients and in 591 (98.7%) of 599 femoral sites. Access-related major adverse events developed in 25 (6.8%) of 367 patients [26/599 (4.3%) sites]. The most frequent adverse event was a hematoma [16/367 (4.4%) patients; 17/599 (2.8% ) sites], followed by pseudoaneurysm [7/367 (1.9%) patients; 7/599 (1.2%) sites]. Bleeding occurred in 6 (1.6%) of 367 patients [6/599 (1.0%) sites]. There were 2 infections, 2 distal embolizations, 1 acute femoral thrombosis, and 1 laceration at the puncture site. Conclusion: The preclose technique can be used to achieve hemostasis with remarkable success and low rates of adverse events.

Original languageEnglish
Pages (from-to)350-355
Number of pages6
JournalJournal of Endovascular Therapy
Volume20
Issue number3
DOIs
Publication statusPublished - 2013 Jun 1

Fingerprint

Stents
Transplants
Safety
Lacerations
False Aneurysm
Thigh
Hemostasis
Punctures
Hematoma
Thrombosis
Hemorrhage
Arteriovenous Fistula
Wounds and Injuries
Femoral Artery
Infection
Medical Records
Leg
Ischemia

All Science Journal Classification (ASJC) codes

  • Surgery
  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

@article{e86bfd8326534ce480e0335744db0b7f,
title = "Efficacy and safety of the preclose technique following percutaneous aortic stent-graft implantation",
abstract = "Purpose: To evaluate in a large patient cohort the 6-F Perclose ProGlide in conjunction with the preclose technique to seal puncture sites after percutaneous endovascular aortic repairs. Methods: The medical records were reviewed of 367 patients (303 men; mean age 68.5±10.8 years) having 599 access site closures with the 6-F Perclose ProGlide performed in conjunction with percutaneous endovascular aortic repairs. Procedure success was defined as hemostasis with the preclose technique without the need for any ancillary procedure. Access-related major adverse events included infection, bleeding, lower leg ischemia, hematoma, pseudoaneurysm, arteriovenous fistula, embolization, laceration, femoral artery thrombosis, nerve injury, or death owing to an access site injury. Results: Procedure success was achieved in 359 (97.8{\%}) of 367 patients and in 591 (98.7{\%}) of 599 femoral sites. Access-related major adverse events developed in 25 (6.8{\%}) of 367 patients [26/599 (4.3{\%}) sites]. The most frequent adverse event was a hematoma [16/367 (4.4{\%}) patients; 17/599 (2.8{\%} ) sites], followed by pseudoaneurysm [7/367 (1.9{\%}) patients; 7/599 (1.2{\%}) sites]. Bleeding occurred in 6 (1.6{\%}) of 367 patients [6/599 (1.0{\%}) sites]. There were 2 infections, 2 distal embolizations, 1 acute femoral thrombosis, and 1 laceration at the puncture site. Conclusion: The preclose technique can be used to achieve hemostasis with remarkable success and low rates of adverse events.",
author = "Kim, {Won Ho} and Sanghoon Shin and Ko, {Young Guk} and Hong, {Myeong Ki} and Yangsoo Jang and Donghoon Choi",
year = "2013",
month = "6",
day = "1",
doi = "10.1583/12-4103MR2.1",
language = "English",
volume = "20",
pages = "350--355",
journal = "Journal of Endovascular Therapy",
issn = "1526-6028",
publisher = "International Society of Endovascular Specialists",
number = "3",

}

Efficacy and safety of the preclose technique following percutaneous aortic stent-graft implantation. / Kim, Won Ho; Shin, Sanghoon; Ko, Young Guk; Hong, Myeong Ki; Jang, Yangsoo; Choi, Donghoon.

In: Journal of Endovascular Therapy, Vol. 20, No. 3, 01.06.2013, p. 350-355.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Efficacy and safety of the preclose technique following percutaneous aortic stent-graft implantation

AU - Kim, Won Ho

AU - Shin, Sanghoon

AU - Ko, Young Guk

AU - Hong, Myeong Ki

AU - Jang, Yangsoo

AU - Choi, Donghoon

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Purpose: To evaluate in a large patient cohort the 6-F Perclose ProGlide in conjunction with the preclose technique to seal puncture sites after percutaneous endovascular aortic repairs. Methods: The medical records were reviewed of 367 patients (303 men; mean age 68.5±10.8 years) having 599 access site closures with the 6-F Perclose ProGlide performed in conjunction with percutaneous endovascular aortic repairs. Procedure success was defined as hemostasis with the preclose technique without the need for any ancillary procedure. Access-related major adverse events included infection, bleeding, lower leg ischemia, hematoma, pseudoaneurysm, arteriovenous fistula, embolization, laceration, femoral artery thrombosis, nerve injury, or death owing to an access site injury. Results: Procedure success was achieved in 359 (97.8%) of 367 patients and in 591 (98.7%) of 599 femoral sites. Access-related major adverse events developed in 25 (6.8%) of 367 patients [26/599 (4.3%) sites]. The most frequent adverse event was a hematoma [16/367 (4.4%) patients; 17/599 (2.8% ) sites], followed by pseudoaneurysm [7/367 (1.9%) patients; 7/599 (1.2%) sites]. Bleeding occurred in 6 (1.6%) of 367 patients [6/599 (1.0%) sites]. There were 2 infections, 2 distal embolizations, 1 acute femoral thrombosis, and 1 laceration at the puncture site. Conclusion: The preclose technique can be used to achieve hemostasis with remarkable success and low rates of adverse events.

AB - Purpose: To evaluate in a large patient cohort the 6-F Perclose ProGlide in conjunction with the preclose technique to seal puncture sites after percutaneous endovascular aortic repairs. Methods: The medical records were reviewed of 367 patients (303 men; mean age 68.5±10.8 years) having 599 access site closures with the 6-F Perclose ProGlide performed in conjunction with percutaneous endovascular aortic repairs. Procedure success was defined as hemostasis with the preclose technique without the need for any ancillary procedure. Access-related major adverse events included infection, bleeding, lower leg ischemia, hematoma, pseudoaneurysm, arteriovenous fistula, embolization, laceration, femoral artery thrombosis, nerve injury, or death owing to an access site injury. Results: Procedure success was achieved in 359 (97.8%) of 367 patients and in 591 (98.7%) of 599 femoral sites. Access-related major adverse events developed in 25 (6.8%) of 367 patients [26/599 (4.3%) sites]. The most frequent adverse event was a hematoma [16/367 (4.4%) patients; 17/599 (2.8% ) sites], followed by pseudoaneurysm [7/367 (1.9%) patients; 7/599 (1.2%) sites]. Bleeding occurred in 6 (1.6%) of 367 patients [6/599 (1.0%) sites]. There were 2 infections, 2 distal embolizations, 1 acute femoral thrombosis, and 1 laceration at the puncture site. Conclusion: The preclose technique can be used to achieve hemostasis with remarkable success and low rates of adverse events.

UR - http://www.scopus.com/inward/record.url?scp=84878935240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878935240&partnerID=8YFLogxK

U2 - 10.1583/12-4103MR2.1

DO - 10.1583/12-4103MR2.1

M3 - Article

C2 - 23731308

AN - SCOPUS:84878935240

VL - 20

SP - 350

EP - 355

JO - Journal of Endovascular Therapy

JF - Journal of Endovascular Therapy

SN - 1526-6028

IS - 3

ER -